Tortugas’ Phase IIb schizophrenia trial of obuprazine meets primary endpoint

​

Tortugas Neuroscience and its partner Hansoh Pharma have reported that their Phase IIb clinical trial of obuprazine for acute schizophrenia achieved its primary endpoint.

The post Tortugas’ Phase IIb schizophrenia trial of obuprazine meets primary endpoint appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.